doi: 10.1111/j.1365-2141.1985.tb04070.x.
The use of danazol in the management of chronic immune thrombocytopenic purpura
- PMID: 4052322
- DOI: 10.1111/j.1365-2141.1985.tb04070.x
Item in Clipboard
The use of danazol in the management of chronic immune thrombocytopenic purpura
Br J Haematol.
1985 Sep.
Abstract
Danazol has recently been reported to be an effective mode of treatment for patients with refractory immune thrombocytopenic purpura. Following a 3 month trial of danazol, only one of 10 patients experienced a sustained increase in platelet counts and two other patients had a transient improvement. While the drug was well tolerated, it does not appear to be particularly helpful in the management of these patients.
Similar articles
-
Danazol in non-splenectomized patients with refractory idiopathic thrombocytopenic purpura.Postgrad Med J. 1990 Oct;66(780):827-30. doi: 10.1136/pgmj.66.780.827. Postgrad Med J. 1990. PMID: 2099421 Free PMC article. Review.
-
Danazol for children with immune thrombocytopenic purpura.Am J Dis Child. 1988 Dec;142(12):1317-9. doi: 10.1001/archpedi.1988.02150120071043. Am J Dis Child. 1988. PMID: 3195531
-
Danazol in refractory autoimmune thrombocytopenic purpura (ATP). A new therapeutic sequence.Arch Invest Med (Mex). 1985 Jul-Sep;16(3):295-304. Arch Invest Med (Mex). 1985. PMID: 3833096 English, Spanish. No abstract available.
-
Danazol therapy in refractory chronic immune thrombocytopenic purpura.Acta Haematol. 1987;77(1):45-7. doi: 10.1159/000205948. Acta Haematol. 1987. PMID: 3107321
-
Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: review of the literature.Vox Sang. 1987;52(3):206-11. doi: 10.1111/j.1423-0410.1987.tb03029.x. Vox Sang. 1987. PMID: 2440183 Review.
Cited by
-
Danazol in non-splenectomized patients with refractory idiopathic thrombocytopenic purpura.Postgrad Med J. 1990 Oct;66(780):827-30. doi: 10.1136/pgmj.66.780.827. Postgrad Med J. 1990. PMID: 2099421 Free PMC article. Review.
-
Immunomodulatory treatments for persistent and chronic immune thrombocytopenic purpura: A PRISMA-compliant systematic review and meta-analysis of 28 studies.Medicine (Baltimore). 2017 Sep;96(37):e7534. doi: 10.1097/MD.0000000000007534. Medicine (Baltimore). 2017. PMID: 28906353 Free PMC article.
-
Idiopathic thrombocytopenic purpura: a retrospective analysis in 139 patients of the influence of age on the response to corticosteroids, splenectomy and danazol.Drugs Aging. 2003;20(11):841-6. doi: 10.2165/00002512-200320110-00005. Drugs Aging. 2003. PMID: 12964890 Review.
-
The thrombocytopenic purpuras. Recognition and management.Drugs. 1996 Jun;51(6):942-53. doi: 10.2165/00003495-199651060-00003. Drugs. 1996. PMID: 8736616 Review.
-
Safety and efficacy of danazol in immune thrombocytopenia: a systematic review.Res Pract Thromb Haemost. 2024 May 17;8(4):102444. doi: 10.1016/j.rpth.2024.102444. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 38988949 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
